Abstract
Gene therapy-induced expression of immunostimulatory molecules at tumor cell level may evoke antitumor immune mechanisms by recruiting and enhancing viability of antigen-processing cells and specific tumoricidal lymphocytes. The antitumor efficacy of a plasmid, coding for granulocyte-macrophage colony-stimulating factor (GM-CSF) and the B7-1 costimulatory immune molecule, delivered into growing solid tumors by electroporation was investigated. Murine fibrosarcomas (JBS) growing in Balb/C mice (
| Original language | English |
|---|---|
| Pages (from-to) | 1061-1071 |
| Number of pages | 11 |
| Journal | Cancer Gene Therapy |
| Volume | 13 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Animals Antigens, CD80/*genetics CD8-Positive T-Lymphocytes/immunology Cell Line, Tumor/pathology Cell Transplantation Cytotoxicity Tests, Immunologic Electroporation/instrumentation/methods Female Fibrosarcoma/genetics/immunology/pathology/*therapy Gene Therapy/*methods Genetic Vectors/genetics/immunology/*pharmacology Granulocyte-Macrophage Colony-Stimulating Factor/*genetics Liver Neoplasms/pathology/secondary/therapy Lymphocytes/immunology Mice Mice, Nude Plasmids/genetics Transfection
Fingerprint
Dive into the research topics of 'Local gene therapy of solid tumors with GM-CSF and B7-1 eradicates both treated and distal tumors'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver